The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Abstract
OBJECTIVE: Neuropsychiatric symptoms are commonly associated with chronic hepatitis C virus infection, its sequelae, and its treatment. In particular, interferon, a primary component of treatment for chronic hepatitis C, has been strongly associated with depressive symptoms. This review summarizes current knowledge about the etiology, course, and treatment of neuropsychiatric problems associated with hepatitis C and interferon alpha (IFN-alpha) treatment. METHOD: Studies were identified by computerized searches, and further references were obtained from bibliographies of the reviewed articles. RESULTS: Chronic infection with the hepatitis C virus is a common and growing problem, often affecting persons with psychiatric and substance use problems. Although changes in cognition, mood, and personality have been described in association with hepatitis C and with IFN-alpha treatment, there has been little systematic study of these changes. CONCLUSIONS: Psychiatrists should become familiar with the clinical spectrum associated with hepatitis C virus infection as well as the neuropsychiatric symptoms related to hepatitis C and IFN-alpha treatment. More studies are necessary to define the neuropsychiatric syndromes associated with this population and to find possible effective treatments. Furthermore, research is needed so that patients with psychiatric problems are not excluded from effective treatments for this growing medical problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Schaff, Z., & Csmos, G. (1994) · Cited by 1,868
The Risk of Transfusion-Transmitted Viral Infections
Schreiber, G. B., Busch, M. P., Kleinman, S. H., & Korelitz, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342601 · Cited by 1,867
Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
Davis, G. L., Balart, L. A., Schiff, E. R., Lindsay, K., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., Dienstag, J. L., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212203 · Cited by 1,633
Davis, G. L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S. C., Trepo, C., Shiffman, M. L., Zeuzem, S., Craxi, A., Ling, M.-H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392102 · Cited by 1,282
Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter
Owens, M. J., & Nemeroff, C. B. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.2.288 · Cited by 929
Delgado, P. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170011002 · Cited by 924
Cytokines and the nervous system II: actions and mechanisms of action
Rothwell, N. J., & Hopkins, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93890-a · Cited by 923
Poynard, T., Leroy, V, Cohard, M., Thevenot, T., Mathurin, P., Opolon, P., & Zarski, J. P. (1996) · Hepatology · doi:10.1002/hep.510240405 · Cited by 671
Conry-Cantilena, C., VanRaden, M., Gibble, J., Melpolder, J., Shakil, A. O., Viladomiu, L., Cheung, L., DiBisceglie, A., Hoofnagle, J., Shih, J. W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342602 · Cited by 627
Cloning of a Serotonin Transporter Affected by Antidepressants
Hoffman, B. J., Mezey, E., & Brownstein, M. J. (1991) · Science · doi:10.1126/science.1948036 · Cited by 611
Clinical toxicity of interferons in cancer patients: a review.
Quesada, J. R., Talpaz, M., Rios, A., Kurzrock, R., & Gutterman, J. U. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.2.234 · Cited by 596
Foster, G. R., Goldin, R. D., & Thomas, H. C. (1998) · Hepatology · doi:10.1002/hep.510270132 · Cited by 562
Hepatitis C and hepatocellular carcinoma
Di Bisceglie, A. M. (1997) · Hepatology · doi:10.1002/hep.510260706 · Cited by 558
Overview: toward a dysregulation hypothesis of depression
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.9.1017 · Cited by 518
The effect of exercise on depression, anxiety and other mood states: A review
Byrne, A., & Byrne, D. G. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90050-p · Cited by 497
Fattovich, G., Giustina, G., Favarato, S., & Ruol, A. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80184-x · Cited by 489
Side effects of high-dose interferon therapy for chronic hepatitis C
Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., Nishioji, K., Katagishi, T., Nakagawa, Y., Tada, H., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80113-9 · Cited by 460
Psychiatric Complications of Long-term Interferon Alfa Therapy
Renault, P. F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090055011 · Cited by 413
Bonkovsky, H. L., & Woolley, M. J. (1999) · Hepatology · doi:10.1002/hep.510290124 · Cited by 398
Side effects of α interferon in chronic hepatitis C
Dusheiko, G. (1997) · Hepatology · doi:10.1002/hep.510260720 · Cited by 397
Benkelfat, C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090019003 · Cited by 336
Mood and cognitive side effects of interferon-alpha therapy.
Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998) · PubMed · Cited by 312
Treatment of Depression Improves Adherence to Interferon Beta-1b Therapy for Multiple Sclerosis
Mohr, D. C., Goodkin, D. E., Likosky, W., Gatto, N., Baumann, K. A., & Rudick, R. A. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170015009 · Cited by 307
Di Bisceglie, A. M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07361-3 · Cited by 288
Dentino, A. N., Pieper, C. F., Rao, K. M. K., Currie, M. S., Harris, T., Blazer, D. G., & Cohen, H. J. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01894.x · Cited by 287
Adrenal Gland Enlargement in Major Depression: A Computed Tomographic Study
Nemeroff, C. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820050048008 · Cited by 283
Blalock, J. E., & Smith, E. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.10.5972 · Cited by 275
The serotonin transporter: a primary target for antidepressant drugs
Schloss, P., & Williams, D. C. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200201 · Cited by 265
Neuropsychiatric Manifestations of Human Leukocyte Interferon Therapy in Patients With Cancer
Adams, F. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350070056026 · Cited by 260
Ellenbogen, M. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00056-5 · Cited by 242
Suicide associated with alfa-interferon therapy for chronic viral hepatitis
Janssen, H. L. A., Brouwer, J. T., van der Mast, R. C., & Schalm, S. W. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80402-7 · Cited by 229
Preziati, D., La Rosa, L., Covini, G., Marcelli, R., Rescalli, S., Persani, L., Del Ninno, E., Meroni, P. L., Colombo, M., & Beck-Peccoz, P. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320587 · Cited by 226
Neurological effects of recombinant human interferon.
Smedley, H., Katrak, M., Sikora, K., & Wheeler, T. (1983) · BMJ · doi:10.1136/bmj.286.6361.262 · Cited by 223
Side Effects of Alpha Interferon
Renault, P., & Hoofnagle, J. (1989) · Seminars in Liver Disease · doi:10.1055/s-2008-1040523 · Cited by 220
Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa
Lisker-Melman, M., Di Bisceglie, A. M., Usala, S. J., Weintraub, B., Murray, L. M., & Hoofnagle, J. H. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90348-3 · Cited by 212
Persistent neurotoxicity of systemically administered interferon‐alpha
Meyers, C. A., Scheibel, R. S., & Forman, A. D. (1991) · Neurology · doi:10.1212/wnl.41.5.672 · Cited by 208
Human leukocyte interferon (HuIFN-α): Potent endorphin-like opioid activity
Blalock, J. E., & Smith, E. M. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91284-5 · Cited by 204
Schiff, E. R. (1997) · Hepatology · doi:10.1002/hep.510260707 · Cited by 180
Depression in the Medically Ill
Cavanaugh, S. V. A. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71707-8 · Cited by 179
NEUROENDOCRINE AND IMMUNE SYSTEM INTERACTIONS IN STRESS AND DEPRESSION
Miller, A. H. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70015-0 · Cited by 177
Capuron, L., & Ravaud, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401716 · Cited by 169
Treatment with interferon-α in patients with chronic hepatitis and mood or anxiety disorders
Pariante, C. M., Orrù, M. G., Baita, A., Farci, M. G., & Carpiniello, B. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04793-x · Cited by 165
Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia
Pavol, M. A., Meyers, C. A., Rexer, J. L., Valentine, A. D., Mattis, P. J., & Talpaz, M. (1995) · Neurology · doi:10.1212/wnl.45.5.947 · Cited by 160
Safety and tolerance of recombinant interferon alfa-2a (roferon®-A) in Cancer Patients
Jones, G. J., & Itri, L. M. (1986) · Cancer · doi:10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f · Cited by 160
Morikawa, O., Sakai, N., Obara, H., & Saito, N. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00187-3 · Cited by 160
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile.
Davis, G. L., Balart, L. A., Schiff, E. R., Lindsay, K. L., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., & Dienstag, J. L. (1994) · PubMed · Cited by 151
Effect of Interferon-α Treatment of Chronic Hepatitis C on Health-Related Quality of Life
Hunt, C. M., Dominitz, J. A., Phillips‐Bute, B. G., Waters, B., Blasi, U., & Williams, D. M. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018852309885 · Cited by 141
Treatment of Neurotoxic Side Effects of Interferon-α with Naltrexone
Valentine, A. D., Meyers, C. A., & Talpaz, M. (1995) · Cancer Investigation · doi:10.3109/07357909509024923 · Cited by 137
Depression From Interferon Therapy in Patients With Hepatitis C
Miyaoka, H., Otsubo, T., Kamijima, K., Ishii, M., ONUKI, M., & Mitamura, K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1120 · Cited by 135
Interferon enhances the excitability of cultured neurones
Calvet, M.-C., & Gresser, I. (1979) · Nature · doi:10.1038/278558a0 · Cited by 129
Fluoxetine treatment of depression caused by interferon-alpha.
Levenson, J. L., & Fallon, H. J. (1993) · PubMed · Cited by 123
Hepatitis C Virus and Depression in Drug Users
Johnson, M. E., Fisher, D. G., Fenaughty, A. M., & Theno, S. A. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.225_a.x · Cited by 122
Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.
Licinio, J., Kling, M. A., & Hauser, P. (1998) · PubMed · Cited by 118
Health assessment for chronic HCV infection
Carithers, R. L., Sugano, D., & Bayliss, M. S. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02087879 · Cited by 117
Mattson, K. V., Niiranen, A., Iivanainen, M., Färkkilä, M. A., Bergström, L., Holsti, L. R., Kauppinen, H., & Cantell, K. (1983) · PubMed · Cited by 108
Morbidity of Chronic Hepatitis C as Seen in a Tertiary Care Medical Center
Lee, D. H., Jamal, H., Regenstein, F., & Perrillo, R. P. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018818012378 · Cited by 104
Effects of interferon alpha on performance in man: a preliminary report
Smith, A. P., Tyrrell, D. A. J., Coyle, K. B., & Higgins, P. (1988) · Psychopharmacology · doi:10.1007/bf00216072 · Cited by 97
Malaguarnera, M., Fazio, I. D., Restuccia, S., Pistone, G., Ferlito, L., & Rampello, L. (1998) · Neuropsychobiology · doi:10.1159/000026485 · Cited by 95
Safety profile of interferon-alpha therapy.
Weiss, K. (1998) · PubMed · Cited by 92
Cognitive functioning in cancer patients
Meyers, C. A., & Abbruzzese, J. L. (1992) · Neurology · doi:10.1212/wnl.42.2.434 · Cited by 85
Singh, N., Gayowski, T., Wagener, M. M., & Marino, I. R. (1997) · Clinical Transplantation · doi:10.1111/j.1399-0012.1997.tb00842.x · Cited by 82
Recent advances in the management of biotherapy-related side effects: fatigue.
Piper, B. F., Rieger, P. T., Brophy, L., Haeuber, D., Hood, L. E., Lyver, A., & Sharp, E. (1990) · PubMed · Cited by 65
Manic episodes in two patients treated with interferon alpha
Strite, D., Valentine, A. D., & Meyers, C. A. (1997) · Journal of Neuropsychiatry · doi:10.1176/jnp.9.2.273 · Cited by 62
Electroencephalographic Abnormalities in Interferon Encephalopathy: A Preliminary Report
Suter, C. C., Westmoreland, B. F., Sharbrough, F. W., & Hermann, R. C. (1984) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65620-1 · Cited by 61
Iivanainen, M., Laaksonen, R. K., Niemi, M., Färkkilä, M. A., Bergström, L., Mattson, K. V., Niiranen, A., & Cantell, K. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1985.tb00904.x · Cited by 60
Successful Treatment of Interferon Alfa-Induced Mood Disorder With Nortriptyline
Goldman, L. S. (1994) · Psychosomatics · doi:10.1016/s0033-3182(94)71769-2 · Cited by 59
Reversible cognitive decline during high-dose α-interferon treatment
Poutiainen, E. T., Hokkanen, L., Niemi, M., & Färkkilä, M. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90294-1 · Cited by 58
Fatigue in patients with cancer receiving interferon alpha.
Dean, G. E., Spears, L., FERRELL, B. R., Quan, W., Groshon, S., & Mitchell, M. (1995) · PubMed · Cited by 55
Merimsky, O., & Chaitchik, S. (1992) · Anti-Cancer Drugs · doi:10.1097/00001813-199212000-00002 · Cited by 52
NOZAKI, O., TAKAGI, C., Takaoka, K., Takata, T., & Yoshida, M. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02579.x · Cited by 49
GHADIRIAN, A. M., Murphy, B. E. P., & Gendron, M. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00053-6 · Cited by 46
Interferon-related mental deterioration and behavioral changes in patients with renal cell carcinoma
Merimsky, O., Reider‐Groswasser, I., Inbar, M., & Chaitchik, S. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90086-9 · Cited by 46
Endocrine and metabolic effects of interferon-alpha in humans
Corssmit, E. P. M., Heijligenberg, R., Endert, E., Ackermans, M. T., Sauerwein, H. P., & Romijn, J. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784081 · Cited by 45
The Hypothalamic–Pituitary–Adrenocortical Axis in Major Depression
Stokes, P. E., & Sikes, C. R. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30430-4 · Cited by 44
L-Tryptophan Augmentation of Light Therapy in Patients with Seasonal Affective Disorder
Lam, R. W. M., Levitan, R. D., Tam, E. M., Yatham, L. N., Lamoureux, S., & Zis, A. P. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200309 · Cited by 38
Burns in a suicide attempt related to psychiatric side effects of interferon
Fukunishi, K., Tanaka, H., Maruyama, J., Takahashi, H., Kitagishi, H., Ueshima, T., Maruyama, K., & Sakata, I. (1998) · Burns · doi:10.1016/s0305-4179(98)00073-4 · Cited by 37
[Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
Otsubo, T., Miyaoka, H., Kamijima, K., ONUKI, M., Ishii, M., & Mitamura, K. (1997) · PubMed · Cited by 35
Provincial Group for the Study of Chronic Liver Disease, Corrao, G., Carle, F., et al. (1992) · European Journal of Epidemiology · doi:10.1007/bf00145376 · Cited by 30
Bipolar disorder associated with interferon-alpha treatment
Iancu, I., Sverdlik, A., Dannon, P. N., & Lepkifker, E. (1997) · Postgraduate Medical Journal · doi:10.1136/pgmj.73.866.834 · Cited by 30
Interferon Treatment of Hepatitis C Associated With Symptoms of PTSD
Maunder, R., Hunter, J., & Feinman, S. V. (1998) · Psychosomatics · doi:10.1016/s0033-3182(98)71308-8 · Cited by 28
Mapou, R. L., Law, W. A., Wagner, K., Malone, J. L., & Skillman, D. R. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.1.74 · Cited by 27
Opioid-dopaminergic mechanisms in the potentiation of d-amphetamine discrimination by interferon-α
Ho, B. T., Huo, Y.-Y., Lu, J., Tansey, L. W., & Levin, V. A. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90446-m · Cited by 26
Amato, R. J., Meyers, C., Ellerhorst, J. A., Finn, L. D., Kilbourn, R. G., Sella, A., & Logothetis, C. J. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059358 · Cited by 19
Barbarino, A., Colasanti, S., Corsello, S. M., Satta, M. A., Casa, S. D., Rota, C. A., Tartaglione, R., & Barini, A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7714107 · Cited by 16
Electrophysiological and Neuropsychological Functions in Patients Treated with Interferon-β
Liberati, A. M., BIAGINI, S., Perticoni, G., RICCI, S., D’Alessandro, P., SENATORE, M., & Cinieri, S. (1990) · Journal of Interferon Research · doi:10.1089/jir.1990.10.613 · Cited by 13
Caraceni (1998) · doi:10.1002/(sici)1097-0142(19980801)83:3
Cited by
Sommereyns, C., Paul, S., Staeheli, P., & Michiels, T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000017 · Cited by 772
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium (2015) · Nature Neuroscience · doi:10.1038/nn.3922 · Cited by 755
Neuropsychiatric Adverse Effects of Interferon-??: Recognition and Management
Raison, C. L., Demetrashvili, M., Capuron, L., & Miller, A. H. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00002 · Cited by 483
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
Black, C., & Miller, B. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.014 · Cited by 366
Metadata
- Authors
- Dieperink, E., Willenbring, M., & Ho, S. B.
- Venue
- American Journal of Psychiatry
- Published
- 2000-06-01
- Volume
- 157
- Issue
- 6
- Pages
- 867-876
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2088732481
- Cited by
- 422
- References
- 93
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.